Clinical Trial Update: Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study [Phase 2, Phase 3]

View source ↗

Summary

A randomized, placebo-controlled Phase 2/3 trial evaluating ataciguat to slow progression of moderate calcific aortic valve stenosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calcific Aortic Valve Stenosis

Drugs mentioned

• Ataciguat (Ataciguat)

Snippet

Sponsor: Kardigan, Inc. | Conditions: Moderate Aortic Valve Stenosis | Phase 2, Phase 3 | Status: RECRUITING